DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
S•••• T••••••••• I••
Biotechnologygroup grade Aon a schedule nowsponsor unattributed
Nothing material in the last 200 days. No dated change on record yet.
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$8,000
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
3
2 on the latest quarter
Facilities
1
2 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2026
Events
4
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | warrants equity W••••••• | Not disclosed | $3,000 2c | |
| O•••••• S•••••••• C••••• F••• | warrants equity W••••••• | Not disclosed | $5,000 2c |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Jun 30, 2024 | at least $25.8M | 103c | S+788 bp | Apr 27, 2029 | 3 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 2 | $0 | $0 | n/a | 0 |
| Mar 31, 2026 | 2 | $0 | $0 | n/a | 0 |
| Dec 31, 2025 | 2 | $0 | $0 | n/a | 0 |
| Sep 30, 2025 | 2 | $0 | $0 | n/a | 0 |
All 16 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | $0 | $0 | n/a | 0 |
| Mar 31, 2025 | 2 | $0 | $0 | n/a | 0 |
| Dec 31, 2024 | 2 | $0 | $0 | n/a | 0 |
| Sep 30, 2024 | 2 | $0 | $0 | n/a | 0 |
| Jun 30, 2024 | 2 | $25.8M | $25.8M | 103c | 0 |
| Mar 31, 2024 | 2 | $25.8M | $24.6M | 99c | 0 |
| Dec 31, 2023 | 2 | $25.8M | $24.7M | 99c | 0 |
| Sep 30, 2023 | 2 | $25.8M | $24.9M | 100c | 0 |
| Jun 30, 2023 | 2 | $25.8M | $24.8M | 100c | 0 |
| Mar 31, 2023 | 1 | $37.5M | $39.0M | 101c | 0 |
| Dec 31, 2022 | 1 | $37.5M | $38.8M | 100c | 0 |
| Sep 30, 2022 | 2 | $0 | $0 | n/a | 0 |
What changed
- Facility left every BDC scheduleJun 30, 2024
- Maturity extended (observed)Jun 30, 2023
- Spread changed (observed)Jun 30, 2023
- New lender joined a facilityJun 30, 2023
- New lender joined a facilityJun 30, 2023
Full timeline · 6 eventsShow fewer
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- S•••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 3 BDCsderived
- Industry
- Biotechnologyreportedas one filer wrote it